Perspective
Published on 01 Dec 2015
Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration “Animal Rule”
in Infectious Agents and Disease
Frontiers in Microbiology
doi 10.3389/fmicb.2015.01320
- 10,420 views
- 78 citations